Get Social With Us
 

BioProcessBlog

Trends and issues in biopharmaceutical development

The Other CAR-T Race: Manufacturing

The biosphere is still buzzing about the FDA’s approval of Kymriah – Novartis’ CAR-T treatment for acute lymphoblastic leukemia that, in many ways, marks the true beginning of the cell and gene therapy era. Approvals of other CAR-Ts are expected soon. But behind the scenes, there’s another race going on:...

Read More

Cheaper Vaccines! Maybe?

I came away from this year’s World Vaccine Congress impressed by two potentially revolutionary technologies that could radically change the cost of vaccines. The first technology, from LimmaTech Biologics AG, is a manufacturing process for producing conjugate vaccines that eliminates the conjugation chemistry steps and further downstream purification by combining the...

Read More